These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9228051)

  • 21. Catabolism of platelet-activating factor and its acyl analog. Differentiation of the activities of lysophospholipase and platelet-activating-factor acetylhydrolase.
    Aarsman AJ; Neys FW; Van den Bosch H
    Eur J Biochem; 1991 Aug; 200(1):187-93. PubMed ID: 1879423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of a method for deactivation of platelet-activating factor:acetylhydrolase in serum for use in in-vitro fertilization culture media.
    Ammit AJ; O'Neill C
    Hum Reprod; 1997 Apr; 12(4):785-91. PubMed ID: 9159443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a major PAF acetylhydrolase in human serum/plasma as a 43 kDa glycoprotein containing about 9 kDa asparagine-conjugated sugar chain(s).
    Akiyama M; Sugatani J; Suzuki T; Suzuki Y; Miwa M
    J Biochem; 1998 May; 123(5):786-9. PubMed ID: 9562606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
    Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
    Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extra- and intracellular metabolism of platelet-activating factor by cultured mesangial cells.
    Neuwirth R; Ardaillou N; Schlondorff D
    Am J Physiol; 1989 Apr; 256(4 Pt 2):F735-41. PubMed ID: 2705543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for an intracellular action of platelet-activating factor in bovine cultured aortic endothelial cells.
    Stewart AG; Dubbin PN; Harris T; Dusting GJ
    Br J Pharmacol; 1989 Mar; 96(3):503-5. PubMed ID: 2497920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.
    Camussi G; Bussolino F; Salvidio G; Baglioni C
    J Exp Med; 1987 Nov; 166(5):1390-404. PubMed ID: 3119758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of newly synthesized platelet-activating factor (PAF) from human polymorphonuclear leukocytes under in vivo conditions. Contribution of PAF-releasing factor in serum.
    Miwa M; Sugatani J; Ikemura T; Okamoto Y; Ino M; Saito K; Suzuki Y; Matsumoto M
    J Immunol; 1992 Feb; 148(3):872-80. PubMed ID: 1730879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
    Parks JE; Hough SR
    J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney.
    Antonopoulou S; Demopoulos CA; Iatrou C; Moustakas G; Zirogiannis P
    Int J Biochem; 1994 Sep; 26(9):1157-62. PubMed ID: 7988740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy.
    Matsubara T; Yasuda K; Johnston JM; Sanezumi M; Okada H; Matsuoka S; Kanzaki H
    Biol Reprod; 1997 Apr; 56(4):885-90. PubMed ID: 9096869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial purification and localization of platelet-activating factor acetylhydrolase from bovine seminal plasma.
    Hough SR; Parks JE
    J Androl; 1997; 18(5):540-8. PubMed ID: 9349753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelium from diverse vascular sources synthesizes platelet-activating factor.
    Whatley RE; Zimmerman GA; McIntyre TM; Prescott SM
    Arteriosclerosis; 1988; 8(3):321-31. PubMed ID: 3130833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
    Ribaldi E; Mezzasoma AM; Francescangeli E; Prosdocimi M; Nenci GG; Goracci G; Gresele P
    Br J Pharmacol; 1996 Jul; 118(6):1351-8. PubMed ID: 8832056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.
    Montrucchio G; Lupia E; Battaglia E; Del Sorbo L; Boccellino M; Biancone L; Emanuelli G; Camussi G
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):80-8. PubMed ID: 10634803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor (PAF)-like activity, localization of PAF receptor (PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy.
    Tiemann U; Tomek W; Schneider F; Wollenhaupt K; Kanitz W; Becker F; Pöhland R; Alm H
    Prostaglandins Other Lipid Mediat; 2001 Jun; 65(2-3):125-41. PubMed ID: 11403499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAF released by preimplantation embryos binds to albumin.
    Ammit AJ; O'Neill C
    Adv Exp Med Biol; 1996; 416():263-7. PubMed ID: 9131159
    [No Abstract]   [Full Text] [Related]  

  • 38. Receptor-dependent metabolism of platelet-activating factor in murine macrophages.
    Ohshima N; Ishii S; Izumi T; Shimizu T
    J Biol Chem; 2002 Mar; 277(12):9722-7. PubMed ID: 11786559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.
    Brizzi MF; Battaglia E; Montrucchio G; Dentelli P; Del Sorbo L; Garbarino G; Pegoraro L; Camussi G
    Circ Res; 1999 Apr; 84(7):785-96. PubMed ID: 10205146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.